Reviva Pharmaceuticals Holdings, Inc. SEC filings RVPH
Reviva Pharmaceuticals Holdings, Inc. has 413 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Oct 29, 2026 | Dec 18, 2026 |
| DEFA14A | Additional proxy material | Dec 5, 2025 | — |
| DEFA14A | Additional proxy material | Nov 4, 2025 | — |
| DEF 14A | Proxy statement | Nov 4, 2025 | Dec 18, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 24, 2025 | Dec 18, 2025 |
| DEF 14A | Proxy statement | Oct 28, 2024 | Dec 10, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 17, 2024 | Dec 10, 2024 |
| DEF 14A | Proxy statement | Oct 4, 2023 | Nov 13, 2023 |
| DEF 14A | Proxy statement | Oct 11, 2022 | Nov 10, 2022 |
| DEF 14A | Proxy statement | Oct 26, 2021 | Dec 8, 2021 |
| DEFA14A | Additional proxy material | Sep 14, 2020 | — |
| DEF 14A | Proxy statement | Sep 9, 2020 | Sep 24, 2020 |
| PRE 14A | Preliminary proxy statement | Aug 25, 2020 | Sep 24, 2020 |
| DEF 14A | Proxy statement | May 6, 2020 | May 21, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 21, 2020 | Apr 21, 2020 |
| DEF 14A | Proxy statement | Feb 6, 2020 | Feb 18, 2020 |
| PRE 14A | Preliminary proxy statement | Jan 16, 2020 | Jan 16, 2020 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RVPH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cupertino, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1742927
- Former names
- Tenzing Acquisition Corp. (until Dec 14, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.